Position in IFRX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$35,840
New position
Shares Held
16,000
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 62 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $181,209,200 across 241 Biotechnology names. IFRX ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in IFRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,840 | 16,000 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||